000			01972 a2200481 4500
005			20250514205907.0
264		0	_c20050217
008			200502s 0 0 eng d
022			_a0013-7227
024	7		_a10.1210/en.2004-0504 _2doi
040			_aNLM _beng _cNLM
100	1		_aAkesson, Lina
245	0	0	_aVPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. _h[electronic resource]
260			_bEndocrinology _cFeb 2005
300			_a744-50 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdipocytes _xdrug effects
650	0	4	_aAnimals
650	0	4	_aCyclic AMP-Dependent Protein Kinase Type II
650	0	4	_aCyclic AMP-Dependent Protein Kinases _xmetabolism
650	0	4	_aGene Expression
650	0	4	_aLipolysis _xdrug effects
650	0	4	_aMale
650	0	4	_aNerve Growth Factors _xmetabolism
650	0	4	_aNeuropeptides _xmetabolism
650	0	4	_aNeurotransmitter Agents _xmetabolism
650	0	4	_aPeptide Fragments _xpharmacology
650	0	4	_aPituitary Adenylate Cyclase-Activating Polypeptide
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, Cell Surface _xantagonists & inhibitors
650	0	4	_aReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide
650	0	4	_aReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
650	0	4	_aReceptors, Vasoactive Intestinal Peptide _xagonists
650	0	4	_aReceptors, Vasoactive Intestinal Peptide, Type II
650	0	4	_aReceptors, Vasoactive Intestinal Polypeptide, Type I
650	0	4	_aVasoactive Intestinal Peptide _xmetabolism
700	1		_aAhrén, Bo
700	1		_aEdgren, Gudrun
700	1		_aDegerman, Eva
773	0		_tEndocrinology _gvol. 146 _gno. 2 _gp. 744-50
856	4	0	_uhttps://doi.org/10.1210/en.2004-0504 _zAvailable from publisher's website
999			_c15202561 _d15202561